NCT00127829View on ClinicalTrials.gov

Study Evaluating Gefitinib (IRESSA®) in Subjects With Solid Malignancies That Are Locally Advanced, Recurrent or Metastatic

PHASE1CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

July 31, 2005

Study Completion Date

January 31, 2008

Conditions
Tumors
Interventions
DRUG

Gefitinib

Oral tablet

Trial Locations (2)

Unknown

Research Site, Los Angeles

Research Site, Palm Springs

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY